Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Factors Likely To Influence AppFolio's (APPF) Q4 Earnings

Published 02/26/2019, 07:08 AM
Updated 07/09/2023, 06:31 AM

AppFolio Inc. (NASDAQ:APPF) is scheduled to release fourth-quarter 2018 results on Feb 28.

Notably, the cloud-based software solutions provider surpassed the Zacks Consensus Estimate in three of the trailing four quarters, pulling off average positive earnings surprise of 18.9%.

In the third quarter, AppFolio reported earnings of 20 cents per share, which soared a whopping 53.8% from the year-ago figure of 13 cents. The figure, however, missed the Zacks Consensus Estimate by a couple of cents.

Revenues surged 32.3% year over year to $50.1 million, beating the consensus estimate by 5.1%.

For the fourth quarter, Zacks Consensus Estimate for earnings is pegged at 20 cents, representing growth of 66.7% from the year-ago quarter whereas the same for the revenues is pegged at $48.1 million, indicating growth of 27%.

Factors at Play in Q4

AppFolio’s sustained focus on product and technology-related innovations to upgrade its solutions meant for property management and legal customers is a key catalyst.

Robust enhancements to its product suite based on customer feedback, which are directed toward making the offerings user friendly, will likely boost engagement, consequently bolstering customer base.

AppFolio recently acquired Dynasty Marketplace, Inc, a provider of advanced artificial intelligence (AI) solutions for the real estate market. The buyout will aid the company’s system of intelligence capabilities to offer higher AI services to real estate customers.

Further, AppFolio has enhanced its Value+ Platform with Renters Insurance product option to tenant users, which is likely to garner incremental revenues. In the third quarter, Value + services revenues surged 42% year over year to $30.8 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Increasing usage of screening services and electronic payments is expected to drive Value+ revenues in the to-be reported quarter. Further, legal liability to landlord insurance from notable property manager customers is likely to be a catalyst.

The company’s AppFolio Property Manager Plus will add robust capabilities, comprising Performance Insights Dashboard, Configurable Workflows, Revenue Management and Optimization, among others.

The company strengthened its MyCase offering with new features that enable customers to send and receive payments. This flexible feature is likely to drive incremental adoption of the solution going ahead, eventually bolstering the top line.

These developments are projected to expand the customer base of the company, which comprised 12,640 property managers (up 12% year over year) and around 10,170 legal customers (up 11% year over year) at the end of the third quarter.

What Our Model Says

According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or #5) are best avoided.

AppFoliohas a Zacks Rank #3 and an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Stocks With a Favorable Combination

Here are some companies, which per our model, have the right combination of elements to post earnings beat in their upcoming releases:

Live Nation Entertainment, Inc. (NYSE:LYV) has an Earnings ESP of +2.41% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Square, Inc. (NYSE:SQ) has an Earnings ESP of +5.95% and a Zacks Rank #2.

AMC Entertainment Holdings, Inc. (NYSE:AMC) has an Earnings ESP of +37.68% and a Zacks Rank #3.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



AppFolio, Inc. (APPF): Free Stock Analysis Report

Square, Inc. (SQ): Free Stock Analysis Report

Live Nation Entertainment, Inc. (LYV): Free Stock Analysis Report

AMC Entertainment Holdings, Inc. (AMC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.